Bruker Corp

US

BRKR

Health Care

78.05 ₽

Current price

Buy
78.05 ₽

Target price 00%

Ranks rating

76

  • Position in sub-industry

    21 / 240

  • Position in country

    1249 / 14179

  • Return on Assets, %

    10.9

    -2.7

  • Net income margin, %

    23.9

    -6.7

  • EBITDA margin, %

    20.3

    5.6

  • Debt to Equity, %

    93

    15.1

  • Intangible assets and goodwill, %

    21.4

    4.7

  • Revenue CAGR 3Y, %

    14.2

    12.8

  • Total Equity change 1Y, %

    23.6

    -2.4

  • Revenue Y, % chg

    17.1

    0

  • P/E

    30.1

    32.1

  • P/BV

    9.2

    2

  • P/S

    4

    4.1

  • EV/S

    4.3

    3.6

  • EV/EBITDA

    19.8

    7.8

  • Average Analyst recommendation

    Buy

    Buy

  • Average upside forecasts, %

    -5.9

    48.9

  • Forward P/E

    29.9

    25.5

  • Dividend Yield, %

    0.2

    0.8

  • Forward Dividend Yield, %

    0.2

    0.2

  • Expected dividend per share

    0.2

    0

  • Payout Ratio, %

    6.8

    10.1

  • Dividend Ex Date

    2024-02-29

Get an analytical review of this company

Competitors

Ranks

  • Bruker Corp

    00%

  • IQVIA Holdings Inc

    00%

  • West Pharmaceutical Services Inc

    00%

  • Agilent Technologies Inc

    00%

  • Avantor Inc

    00%

  • Thermo Fisher Scientific Inc

    00%

  • Danaher Corp

    00%

  • Waters Corp

    00%

  • Mettler-Toledo International Inc

    00%

  • Illumina Inc

    00%

Ready-made portfolio of the best Russian stocks

  • Created by artificial intelligence
  • Verified by analysts
  • Available even to beginners

Company information

  • Country

    United States of America

  • Sector

    Health Care

  • Industry group

    Pharmaceuticals, Biotechnology & Life Sciences

  • Industry

    Life Sciences Tools & Services

  • Sub-sector

    Health Care

  • Capitalization (millions of $)

    12057.2

  • Ticker

    BRKR.O

  • ISIN

    US1167941087

  • IPO date

    2000-08-04

  • Availability on Russian exchanges

    Yes

  • Reporting for

    2024-02-29

  • Date fact. publication of reports

    2023-12-31

Company Description

Bruker Corporation is a developer, manufacturer, and distributor of scientific instruments and analytical and diagnostic solutions. The Company operates through four segments: Bruker BioSpin Group, Bruker CALID Group, Bruker Scientific Instruments (BSI) Nano Group and Bruker Energy & Supercon Technologies (BEST). The Bruker BioSpin Group segment designs, manufactures, and distributes enabling life science tools based on magnetic resonance technology. The Bruker CALID Group segment designs, manufactures, and distributes life science mass spectrometry and ion mobility spectrometry solutions, analytical and process analysis instruments, and solutions. The BSI NANO Group segment designs and manufactures advanced X-ray instruments; advanced fluorescence optical microscopy instruments; analytical tools for electron microscopes and X-ray metrology; and defect-detection equipment. The BEST segment develops and manufactures superconducting and non-superconducting materials and devices.

A step towards better analytics

  • find the best promotions through the Screener
  • keep an eye on stock valuation
  • download detailed reports

and much more after free registration

Registration

More convenient from your phone? Download: